comparemela.com
Home
Live Updates
Biotechnology 121 - Breaking News
Pages:
10
11
12
13
14
15
16
Latest Breaking News On - Biotechnology 121 - Page 9 : comparemela.com
2022-11-24 | TSXV:NRX | Press Release | NurExone Biologic Inc
(2022-11-24 | TSXV:NRX) NurExone Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Israel general
United states
Hebrew university
James jay richardson
Lior shaltiel
Nurexone exotherapy
Burstyn cohen lab
Company or nurexone
Company on
Enerspar corp
Nurexone biologic inc
Company exotherapy
Alberta newsfile corp
Yissum research development company
Drug administration
Nanometrix ltd
2022-11-22 | NDAQ:DRTS | Press Release | Alpha Tau Medical Ltd
(2022-11-22 | NDAQ:DRTS) Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
United kingdom
Israel general
United states
Christopher barker
Itzhak kelson
Peter melnyk
Alpha da
Yona keisari
University of texas md anderson cancer center
Radiation research society closecurlyquote
International journal of radiation oncology
Company closecurlydoublequote
Alpha tau medical ltd
Exchange commission
Regulatory agency of the united kingdom
American society for radiation oncology
2022-11-18 | NDAQ:PALI | Press Release | Palisade Bio Inc
(2022-11-18 | NDAQ:PALI) Palisade Bio Appoints Herbert B. Slade, MD, FAAAAI as Chief Medical Officer
United states
New york
Texas college
Hamilton college
Jenene thomas
Slade closecurlyquote
Jonas salk
Herbertb slade
S uny upstate medical center
Texas college of osteopathic medicine
Research development
University of michigan
Palisade bio inc
Cornell university medical college
Chisholm clinical research services
Company closecurlyquote
2022-11-11 | TSX:FRX | Press Release | Fennec Pharmaceuticals Inc
(2022-11-11 | TSX:FRX) Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update
United states
Robert andrade
Lindsay rocco
Rosty raykov
Science university
Fennec pharmaceuticals
Fennec pharmaceuticals inc
Oregon health
Exchange commission
Development rd expenses
Company closecurlyquote
Elixir health public relations
Approved therapy indicated
Ototoxicity associated
Pediatric patients
Non metastatic tumors
2022-11-09 | NDAQ:SMMT | Press Release | Summit Therapeutics Inc
(2022-11-09 | NDAQ:SMMT) Summit Therapeutics Inc. Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022
Stanford university
United states
United kingdom
Menlo park
Maky zanganeh
Robert booth
Robertw duggan
Dave gancarz
Stanford university school of medicine
Cymabay inc
Company ri
Company closecurlyquote
Summit therapeutics inc
Celera genomics inc
Biomedical advanced research
Human services
vimarsana © 2020. All Rights Reserved.